News
All NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents
Multimedia
All VideosAsk the ExpertBehind the HeadlinesBuy, Sell, HoldPeer ExchangePivotal Papers
Publication
Conferences
Conference ListingLatest Conference Content
More
Resources
Podcast SeriesBiopharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts

Subscribe

  • News
  • Multimedia
  • Publication
  • Conferences
  • Resources
  • Subscribe
  • Webcasts
  • BioBusiness
    • Partnerships
    • Funding and Investments
    • Intellectual Property & Patents
    • Biologic Drugs in Development
    • Mergers and Acquisitions
  • BioPharm Products
  • BioPharm Sponsored Ad
  • Biopharmaceutical Analysis
    • Analytical Best Practices
    • Analytical Methods
    • Lab Furnishings and Equipment
    • Contract Analytical Services
    • Finished Product Analysis
    • Drug Substance Analysis
    • Biopharmaceutical Analysis: GC-MS
    • Biopharmaceutical Analysis: Mass Spectrometry
    • Biopharmaceutical Analysis: ICP-MS
    • Biopharmaceutical Analysis: NMR
    • Biopharmaceutical Analysis: Raman
    • Biopharmaceutical Analysis: Gas Chromatography
    • Biopharmaceutical Analysis: LC-MS
    • Biopharmaceutical Analysis: HPLC/UHPLC
    • Analytical Instrumentation
  • Biosimilars and Biobetters
  • Deals, Development and Manufacturing
  • Development
    • Formulation
    • Process Validation
    • Drug Delivery
    • Process Development
    • Scale Up
    • Excipients
    • API Synthesis and Manufacturing, Large Molecule
    • Formulation and Drug Delivery, Combination Drugs
    • Early Phase Development
    • Formulation and Drug Delivery, Biologic Drugs
    • Formulation and Drug Delivery, Parenterals
    • Formulation and Drug Delivery, Specialty Dosage Forms
    • Formulation and Drug Delivery, Controlled Release
    • Formulation and Drug Delivery, Liquids
    • Formulation and Drug Delivery, Solid Dosage
    • Formulation and Drug Delivery, Other
  • Discovery Pipeline
  • Disposables Advisor
  • Downstream Processing
    • Viral Clearance
    • Manufacturing, Separation and Purification
    • Manufacturing Equipment, Downstream Processing
    • Manufacturing, Process Chromatography
  • Elements of Biopharmaceutical Production
  • From the CEO
  • From the Editor
  • Inside Standards
  • Interphex Keynote Sessions
  • Manufacturing
    • Manufacturing, Monoclonal Antibodies
    • Manufacturing Systems, Single-Use
    • Vaccine Development and Manufacturing
    • Manufacturing, Aseptic Processing
    • Manufacturing, Fill/Finish
    • Facility Design and Engineering
    • Process Control, Automation, and PAT
    • Supply Chain/Logistics
    • Manufacturing Best Practices
    • Information Technology
    • Technology Transfer
    • Manufacturing Equipment, Upstream Processing
    • Manufacturing Equipment, Biologics
    • Cleanroom Equipment and Supplies
    • Manufacturing, Parenterals and Injectables
    • Clinical Trial Materials
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Lyophilization
    • Manufacturing, Combination Drugs
    • Manufacturing, Solid Dosage Drugs
    • Manufacturing, Topical Drugs
    • Manufacturing, Biologics
    • Manufacturing, Specialty Dosage Forms
    • Manufacturing, Nucleic Acids
    • Manufacturing, Liquid Drug Products
    • Manufacturing, Drug Products
    • Manufacturing, Cell Therapies
    • Manufacturing, Recombinant Proteins
    • Manufacturing, Continuous Biologics Processing
    • Manufacturing, Gene Therapies
    • Packaging, Labeling, and Distribution Systems
  • Outsourcing
    • Clinical Trial Services
    • Perspectives on Outsourcing
    • Contract Services, Regulatory Consulting
    • Contract Packaging, Logistics, and Distribution
    • Contract Manufacturing, Sterile, Aseptic Processing
    • Contract Manufacturing, Biopharmaceutical Production
    • Contract Manufacturing, Drug Substance, API
    • Contract Manufacturing, Finished Drug Product
    • Contract Manufacturing, General
    • Contract Services, Formulation and Drug Delivery
  • Peer-Reviewed Research
  • Pharmacopoeial Compliance Series
  • Quality/GMPs
    • Ask the Expert
    • Regulatory/GMP Compliance
    • Compliance Notes
    • Regulatory Beat
    • European Regulatory Watch
    • Adverse Events and Recalls
    • Regulatory/GMP Compliance, Europe
    • Regulatory/GMP Compliance, Emerging Markets
    • Audits and Inspections
    • Anticounterfeiting, Track and Trace Systems
    • Quality by Design
    • Compendial Compliance
    • Standard Operating Procedures (SOPs)
    • Quality Control/Quality Assurance
    • Regulatory Filings and Submissions
    • Regulatory Authority Actions
  • Therapeutic Specific Areas
  • Upstream Processing
    • Manufacturing, Cell-Line Selection
    • Manufacturing, Expression Systems
    • Manufacturing, Cell Culture and Fermentation
  • Viewpoints
  • Weighing Up Big Pharma
Spotlight -
Analytics|
Development|
Downstream Processing|
Manufacturing|
Outsourcing|
Quality/GMPs|
Upstream Processing
Advertisement

Formulation and Drug Delivery, Liquids

Latest News

QA-Schott_117169218-814882-1408536787474.jpg
June 1st 2013
Using Plastic for Parenteral Containers
By Jennifer Markarian

A Q&A with SCHOTT Pharmaceutical Systems and West Pharmaceutical Services

Table-1_t-791282-1408596013718.jpg
October 1st 2012

Moisture Matters in Lyophilized Drug Product

By Leu-Fen H. Lin, PhD, Richard Bunnell, PhD
Table1-742603-1408614973235.jpg
October 1st 2011

Contract Services Spending: Who's Spending What, and Where?

By Kate Hammeke
VetterGroundbreaking-675218-1408633518086.gif
June 18th 2010

Vetter Aims to Optimize Logistics with a New Facility in Ravensburg

By Chitra Sethi
Fig7_particle_counts-601406-1408647772945.gif
June 1st 2009

Best Practices for Formulation and Manufacturing of Biotech Drug Products

By Satish K. Singh, Arnold McAuley, Nitin Rathore
Advertisement

Advertisement
Fig1_Specifying_dispos_t-568931-1408673348915.gif

Disposable Technologies Implementation: Understanding and Managing Risks

ByMiriam Monge,Andrew Sinclair
December 1st 2008

In new disposables projects, it is critical that engineering, procurement, and operations groups work together early on to manage supply chain risk.

Fig5_Process_capability-532061-1408661332170.jpg

A Rational Approach for Setting and Maintaining Specifications for Biological and Biotechnology–Derived Products—Part 3

August 1st 2008

Set limits to provide incentives for process improvements.

Fig2_ds_quality_attribute-527447-1408666198078.jpg

A Rational Approach for Setting and Maintaining Specifications for Biological and Biotechnology–Derived Products—Part 2

July 1st 2008

Resolve confusion about measurements.

  • Prev
  • 1
  • 2
  • Prev
Advertisement
Advertisement

Trending on BioPharm International

1

BioPharm Weekly News Roundup—Week of Oct. 13, 2025

  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us